Powder: -20°C for 3 years
In solvent: -80°C for 2 years
FASN-IN-3 is an inhibitor of fatty acid synthase (FASN).
Description | FASN-IN-3 is an inhibitor of fatty acid synthase (FASN). |
In vitro | For monocytes, FASN-IN-3 treatment reduces the level of IL-1 beta resulting from LTA stimulation whereas there is only a slight reduction after LPS stimulation.Human PBMC and monocytes in cell cultures are stimulated with lipopolysaccharide (LPS), a Toll 4 receptor agonist, or lipoteichoic acid (LTA), a Toll 2 receptor agonist.?Stimulation with either LPS or LTA plus DMSO, the solvent for FASN-IN-3 , results in secretion of IL-1 beta.?FASN inhibitor 1 treatment of PBMC, which is a mixed population of mononuclear cells including both lymphocytes and monocytes, reduces the level of IL-1 beta resulting from either LPS or LTA stimulation. |
Molecular Weight | 384.47 |
Formula | C24H24N4O |
CAS No. | 2097262-60-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 33.33 mg/mL (86.69 mM), ultrasonic and warming and heat to 80°C
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FASN-IN-3 2097262-60-5 代谢 Fatty Acid Synthase Fatty Acid Synthase (FASN) Inhibitor inhibit FASNIN3 FASN IN 3 inhibitor